Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Biotron.
RELATED STOCKHEAD STORIES
News
Rise and Shine: What you need to know before the ASX opens
News
November Winners: ASX investors were spooked by Omicron, but wooed by Julimar, hydrogen and the metaverse
Health & Biotech
As Biotron more than doubles on promising COVID results, which other ASX stocks are working on treatments?
News
ASX Small Cap Lunch Wrap: Who’s tapping into strategic reserves today?
News
10 at 10: Investors in these ASX stocks can see light at the end of the tunnel this morning
News
Weekly Small Cap and IPO Wrap: How did this week’s five IPOs perform?
News
Market Highlights and 5 ASX Small Caps to watch on Friday
News
Closing Bell: One biotech more than doubles, another drops 30pc on debut
News
ASX Small Cap Lunch Wrap: Who’s not getting what they paid for today?
Health & Biotech
ASX Health Stocks: Biotron gets a boost with promising in vivo study for COVID-19 treatment
News
10 at 10: These ASX stocks are the most imposing this morning
Health & Biotech
AstraZeneca’s COVID-19 fight hits the skids; ASX small cap Biotron says ‘We’re on track’
Health & Biotech
Pharmaxis dealt another blow as partner backs out of second drug development
News
10 at 10: These ASX stocks are leading the rally this morning
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
